These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [A bactericidal-fungicidal fluid (BFZh-28) in the therapy of various skin diseases]. Vinokurov IN; Ukhova LS Vestn Dermatol Venerol; 1967 Jul; 41(7):91. PubMed ID: 5621120 [No Abstract] [Full Text] [Related]
28. [Pimecrolimus (SDZ ASM 981). Current state of research]. Dissemond J; Goos M; Wagner SN Dtsch Med Wochenschr; 2002 May; 127(22):1199-203. PubMed ID: 12035117 [No Abstract] [Full Text] [Related]
29. [Dermatologic and venerologic therapy 1946/1986]. Ippen H Z Hautkr; 1986 Dec; 61(23):1711-5. PubMed ID: 3544546 [No Abstract] [Full Text] [Related]
30. [To the restitution of the acid cover]. Fisher M Landarzt; 1967 Feb; 43(6):IV-IX. PubMed ID: 5591256 [No Abstract] [Full Text] [Related]
31. Sources of drug information: FDA-approved labeling and other official FDA sources. Lindstrom JA Dermatol Ther; 2009; 22(3):246-56. PubMed ID: 19453349 [TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity? van de Kerkhof PC; Mrowietz U; Segaert S; Kragballe K Br J Dermatol; 2007 Apr; 156(4):771-2. PubMed ID: 17263798 [No Abstract] [Full Text] [Related]
33. [Dermatologic treatment. The Danish Society of Dermatology]. Olesen AK; Jemec GB Ugeskr Laeger; 2003 Mar; 165(12):1228. PubMed ID: 12701278 [No Abstract] [Full Text] [Related]
34. The facts about treatment of dry skin. Dotz W; Berman B Geriatrics; 1983 Sep; 38(9):93-5, 99-100. PubMed ID: 6884777 [No Abstract] [Full Text] [Related]
35. Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA). Weaver J; Grenade LL; Kwon H; Avigan M Dermatol Ther; 2009; 22(3):204-15. PubMed ID: 19453344 [TBL] [Abstract][Full Text] [Related]
37. Skin protectant drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment. Food and Drug Administration, HHS Fed Regist; 2003 Dec; 68(236):68509-11. PubMed ID: 14664244 [TBL] [Abstract][Full Text] [Related]
38. [Recommendation for a prescription of an emulsion for the care of sensitive and diseased skin]. Albrecht-Nebe H; Bolle I Dermatol Monatsschr; 1985; 171(7):449-50. PubMed ID: 4043461 [No Abstract] [Full Text] [Related]
39. Bias shown in study of better care for patients with skin disease? Ober V; Meires J Fam Med; 2001 Feb; 33(2):82-3. PubMed ID: 11271743 [No Abstract] [Full Text] [Related]
40. Use of dermatologic agents. How they differ worldwide. Tronnier H; Kalinka P Int J Dermatol; 1991 Aug; 30(8):558-9. PubMed ID: 1938052 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]